Oaktree Acquisition Corp. III Life Sciences (OACCU) Payables (2024 - 2026)
Oaktree Acquisition Corp. III Life Sciences' (OACCU) quarterly Payables came in at $763287.0 in Q1 2026, up 87.31% YoY from $407510.0 in Q1 2025, and up 48.56% on a QoQ basis from $513792.0 in Q4 2025.
Oaktree Acquisition Corp. III Life Sciences (OACCU) Payables (2024 - 2026) Analysis & Trends
Oaktree Acquisition Corp. III Life Sciences (OACCU) has 3 years of Payables data on file, last reported at $763287.0 in Q1 2026.
- Quarterly Payables rose 87.31% year-over-year to $763287.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $763287.0 (up 87.31% YoY) and the FY2025 annual result came in at $513792.0, down 6.13% from the prior year.
- Payables grew to $763287.0 in Q1 2026, from $513792.0 in the prior quarter.
- In the past five years, Payables ranged from a high of $763287.0 in Q1 2026 to a low of $393378.0 in Q2 2025.
- A 3-year average of $508539.5 and a median of $469861.5 in 2025 frame the typical range for Payables.
- Annual changes were most pronounced in 2025 — Payables fell 6.13% — and 2026, when it soared 87.31%.
- Tracing OACCU's Payables over 3 years: stood at $547339.0 in 2024, then declined by 6.13% to $513792.0 in 2025, then jumped by 48.56% to $763287.0 in 2026.
- The last three Payables figures came in at $763287.0 (Q1 2026), $513792.0 (Q4 2025), and $425931.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 793,976.00 |
| Mar 31, 2026 | 763,287.00 |
| Dec 31, 2025 | 513,792.00 |
| Sep 30, 2025 | 425,931.00 |
| Jun 30, 2025 | 393,378.00 |
| Mar 31, 2025 | 407,510.00 |
| Dec 31, 2024 | 547,339.00 |